$Innoviva (INVA.US)$🎯 2023.8.11 Current price is 13.5, posi...

New data: 2022/Q4 and the whole year, the first two quarters of 2023

In 2022 Q4, revenue fell 38.9%, operating profit fell 76.9%, and net profit turned into loss. This resulted in revenue falling 15.5%, operating profit falling 44.8%, and net profit falling 40.3% for the full year of 2022.

In the first two quarters of 2023, revenue fell 20.6%, operating profit fell 63.6%, and net profit fell 39%.

Currently, the price-earnings ratio is 5.7, and the price-earnings ratio TTM has dropped slightly to 5.2. Since the revenue from the sale of the 270 million business in Q3 last year increased net profit, without this portion of revenue this year, the net profit is likely to be between 500 million and 100 million. The corresponding price-earnings ratio is between 8.8 and 17.6. It doesn't seem that high, and there is no need for adjustment for the time being.